Register entry

Miyoshi America, Inc.

Registered sites
2
Drug products
24
Live patents
0
Countries
2
Base
United States
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Active ingredient (API) manufactureLabellingPackaging
Sites

Facilities

2
SiteLocationOperationsFEI
MIYOSHI EUROPESaint PriestFranceActive ingredient (API) manufacture, Labelling, Packaging3010288733
Miyoshi America, Inc.Dayville, CTUnited StatesActive ingredient (API) manufacture, Labelling, Packaging3009481791
Catalogue

Marketed products

24

Showing 24 of 24.

BrandGeneric nameFormCategory
-TITANIUM DIOXIDEPOWDERDRUG FOR FURTHER PROCESSING
-TITANIUM DIOXIDEPOWDERDRUG FOR FURTHER PROCESSING
-TITANIUM DIOXIDEPOWDERDRUG FOR FURTHER PROCESSING
-TITANIUM DIOXIDESOLUTIONDRUG FOR FURTHER PROCESSING
-TITANIUM DIOXIDESOLUTION, CONCENTRATEDRUG FOR FURTHER PROCESSING
-TITANIUM DIOXIDESOLUTIONDRUG FOR FURTHER PROCESSING
-TITANIUM DIOXIDESOLUTIONDRUG FOR FURTHER PROCESSING
-TITANIUM DIOXIDEPOWDERDRUG FOR FURTHER PROCESSING
-TITANIUM DIOXIDEPOWDER, FOR SOLUTIONDRUG FOR FURTHER PROCESSING
-TITANIUM DIOXIDEPOWDER, FOR SOLUTIONDRUG FOR FURTHER PROCESSING
-Titanium DioxidePOWDERDRUG FOR FURTHER PROCESSING
-Titanium DioxidePOWDERDRUG FOR FURTHER PROCESSING
-Titanium DioxidePOWDERDRUG FOR FURTHER PROCESSING
-Titanium DioxidePOWDERDRUG FOR FURTHER PROCESSING
-Titanium DioxidePOWDERDRUG FOR FURTHER PROCESSING
-Titanium DioxidePOWDERDRUG FOR FURTHER PROCESSING
-Titanium dioxidePOWDERDRUG FOR FURTHER PROCESSING
-ZINC OXIDEPOWDERDRUG FOR FURTHER PROCESSING
-Zinc OxidePOWDER, FOR SOLUTIONDRUG FOR FURTHER PROCESSING
-Zinc OxidePOWDERDRUG FOR FURTHER PROCESSING
-Zinc OxideLIQUIDDRUG FOR FURTHER PROCESSING
-Zinc OxidePOWDERDRUG FOR FURTHER PROCESSING
-Zinc OxidePOWDERDRUG FOR FURTHER PROCESSING
-Zinc OxidePOWDERDRUG FOR FURTHER PROCESSING
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.